Amylx Pharmaceuticals Inc vs Vistra Corp — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Vistra Corp trades at $146.04 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 18.4× Amylx Pharmaceuticals Inc's market cap, and Vistra Corp pays a 0.63% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | VST | |
|---|---|---|
Market Cap | $2.64B | $48.64B |
Sector | Health | Technology |
52-Week High | $24.19 | $217.92 |
52-Week Low | $7.82 | $134.71 |
Enterprise Value | $2.39B | $70.58B |
Dividend Yield | — | 0.63% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →